U.S., Dec. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07290621) titled 'Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer' on Dec. 12.
Brief Summary: This is a single-center phase 2 study of to test how well the combination of toripalimab with chemotherapy followed by TORS or risk and response stratified de-escalated (chemo)radiotherapy works in patients with in HPV16+ locoregionally advanced oropharyngeal cancer (OPC).
Study Start Date: Feb., 2026
Study Type: INTERVENTIONAL
Condition:
Oropharyngeal Cancer
Intervention:
DRUG: Toripalimab
Toripalimab will be given by Intravenous (IV) infusion once on Day 1 of each treatment cycle. Up to 3 cycl...